{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:18:16Z","timestamp":1762255096834,"version":"3.40.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81801736"],"award-info":[{"award-number":["No.81801736"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key project of Anhui Provincial Education Department","award":["KJ2021A0290"],"award-info":[{"award-number":["KJ2021A0290"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02567-7","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T03:14:08Z","timestamp":1745205248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["68Ga-labeled prostate specific membrane antigen HBED-CC PET\/MRI for staging and evaluating the clinicopathological characteristics in newly diagnosed prostate cancer"],"prefix":"10.1186","volume":"30","author":[{"given":"Xiaoyu","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"issue":"4","key":"2567_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2174\/157892818666230419081414","volume":"19","author":"Y Liu","year":"2024","unstructured":"Liu Y, Hao L, Dong Y, Dong BZ, Wang XL, Liu X, et al. Co-delivery of siape1 and melatonin by 125I-loaded PSMA-targeted nanoparticles for the treatment of prostate cancer. Recent Pat Anticancer Drug Discov. 2024;19(4):503\u201315. https:\/\/doi.org\/10.2174\/157892818666230419081414.","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"1","key":"2567_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40779-024-00566-z","volume":"11","author":"JK Li","year":"2024","unstructured":"Li JK, Tang T, Zong H, Wu EM, Zhao J, Wu RR, et al. Intelligent medicine in focus: the 5 stages of evolution in robot-assisted surgery for prostate cancer in the past 20 years and future implications. Mil Med Res. 2024;11(1):58. https:\/\/doi.org\/10.1186\/s40779-024-00566-z.","journal-title":"Mil Med Res"},{"issue":"1","key":"2567_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s40001-024-01672-3","volume":"29","author":"B Hu","year":"2024","unstructured":"Hu B, Zhang X, Zhu S, Wang C, Deng Z, Wang T, et al. Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironment. Eur J Med Res. 2024;29(1):92. https:\/\/doi.org\/10.1186\/s40001-024-01672-3.","journal-title":"Eur J Med Res"},{"issue":"2","key":"2567_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108. https:\/\/doi.org\/10.3322\/caac.21262.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2567_CR5","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s40001-023-01590-w","volume":"28","author":"H Zhang","year":"2023","unstructured":"Zhang H, Xiao L, Xie H, Li L. Hotspots and frontiers in PSMA research for prostate cancer: a bibliometric and visualization analysis over the past 20 years. Eur J Med Res. 2023;28(1):610. https:\/\/doi.org\/10.1186\/s40001-023-01590-w.","journal-title":"Eur J Med Res"},{"issue":"4","key":"2567_CR6","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s00268-005-0544-5","volume":"30","author":"Y Kinoshita","year":"2006","unstructured":"Kinoshita Y, Kuratsukuri K, Landas S, Imaida K, Rovito PM Jr, Wang CY, et al. Expression of prostate-specific membrane antigen in normal and malignant human tissues. World J Surg. 2006;30(4):628\u201336. https:\/\/doi.org\/10.1007\/s00268-005-0544-5.","journal-title":"World J Surg"},{"issue":"1","key":"2567_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/diagnostics8010016","volume":"8","author":"NP Lenzo","year":"2018","unstructured":"Lenzo NP, Meyrick D, Turner JH. Review of gallium-68 PSMA PET\/CT imaging in the management of prostate cancer. Diagnostics (Basel). 2018;8(1):16. https:\/\/doi.org\/10.3390\/diagnostics8010016.","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"2567_CR8","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","volume":"44","author":"WP Fendler","year":"2017","unstructured":"Fendler WP, Eiber M, Beheshti M, Bomanji J, Ceci F, Cho S, et al. 68Ga-PSMA PET\/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2017;44(6):1014\u201324. https:\/\/doi.org\/10.1007\/s00259-017-3670-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"2567_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1056\/NEJMc080867","volume":"359","author":"JS Yu","year":"2008","unstructured":"Yu JS, Roach M 3rd. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;359(2):200\u20132. https:\/\/doi.org\/10.1056\/NEJMc080867.","journal-title":"N Engl J Med"},{"issue":"1","key":"2567_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41379-020-0625-x","volume":"34","author":"E Hollemans","year":"2021","unstructured":"Hollemans E, Verhoef EI, Bangma CH, Rietbergen J, Osanto S, Pelger RCM, et al. Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients. Mod Pathol. 2021;34(1):184\u201393. https:\/\/doi.org\/10.1038\/s41379-020-0625-x.","journal-title":"Mod Pathol"},{"issue":"7","key":"2567_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00345-015-1510-y","volume":"33","author":"A Karl","year":"2015","unstructured":"Karl A, Buchner A, Tympner C, Kirchner T, Ganswindt U, Belka C, et al. The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence. World J Urol. 2015;33(7):973\u20139. https:\/\/doi.org\/10.1007\/s00345-015-1510-y.","journal-title":"World J Urol"},{"issue":"15","key":"2567_CR12","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/pros.23067","volume":"75","author":"S Ciftci","year":"2015","unstructured":"Ciftci S, Yilmaz H, Ciftci E, Simsek E, Ustuner M, Yavuz U, et al. Perineural invasion in prostate biopsy specimens is associated with increased bone metastasis in prostate cancer. Prostate. 2015;75(15):1783\u20139. https:\/\/doi.org\/10.1002\/pros.23067.","journal-title":"Prostate"},{"issue":"12","key":"2567_CR13","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.2967\/jnumed.117.193581","volume":"58","author":"S Schmuck","year":"2017","unstructured":"Schmuck S, von Klot CA, Henkenberens C, Sohns JM, Christiansen H, Wester HJ, et al. Initial experience with volumetric 68Ga-PSMA I&T PET\/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with prostate cancer. J Nucl Med. 2017;58(12):1962\u20138. https:\/\/doi.org\/10.2967\/jnumed.117.193581.","journal-title":"J Nucl Med"},{"issue":"12","key":"2567_CR14","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1097\/RLU.0000000000002289","volume":"43","author":"N Erg\u00fcl","year":"2018","unstructured":"Erg\u00fcl N, Yilmaz G\u00fcne\u015f B, Y\u00fcceta\u015f U, Tokta\u015f MG, \u00c7ermik TF. 68Ga-PSMA-11 PET\/CT in newly diagnosed prostate adenocarcinoma. Clin Nucl Med. 2018;43(12):e422\u20137. https:\/\/doi.org\/10.1097\/RLU.0000000000002289.","journal-title":"Clin Nucl Med"},{"issue":"4","key":"2567_CR15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1021\/bc200279b","volume":"23","author":"M Eder","year":"2012","unstructured":"Eder M, Sch\u00e4fer M, Bauder-W\u00fcst U, Hull WE, W\u00e4ngler C, Mier W, et al. 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging. Bioconjug Chem. 2012;23(4):688\u201397. https:\/\/doi.org\/10.1021\/bc200279b.","journal-title":"Bioconjug Chem"},{"issue":"9","key":"2567_CR16","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.2967\/jnumed.115.171249","volume":"57","author":"A Amor-Coarasa","year":"2016","unstructured":"Amor-Coarasa A, Schoendorf M, Meckel M, Vallabhajosula S, Babich JW. Comprehensive quality control of the ITG 68Ge\/68Ga generator and synthesis of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for clinical imaging. J Nucl Med. 2016;57(9):1402\u20135. https:\/\/doi.org\/10.2967\/jnumed.115.171249.","journal-title":"J Nucl Med"},{"issue":"7","key":"2567_CR17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/ph7070779","volume":"7","author":"M Eder","year":"2014","unstructured":"Eder M, Neels O, M\u00fcller M, Bauder-W\u00fcst U, Remde Y, Sch\u00e4fer M, et al. Novel preclinical and radiopharmaceutical aspects of [68Ga]Ga-PSMA-HBED-CC: a new PET tracer for imaging of prostate cancer. Pharmaceuticals (Basel). 2014;7(7):779\u201396. https:\/\/doi.org\/10.3390\/ph7070779.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"2567_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/aja.aja_24_17","volume":"21","author":"S Gasparrini","year":"2017","unstructured":"Gasparrini S, Cimadamore A, Scarpelli M, Massari F, Doria A, Mazzucchelli R, et al. Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians. Asian J Androl. 2017;21(1):19\u201323. https:\/\/doi.org\/10.4103\/aja.aja_24_17.","journal-title":"Asian J Androl"},{"issue":"1","key":"2567_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","volume":"69","author":"JC Weinreb","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, et al. PI-RADS prostate imaging-reporting and data system: 2015, Version 2. Eur Urol. 2016;69(1):16\u201340. https:\/\/doi.org\/10.1016\/j.eururo.2015.08.052.","journal-title":"Eur Urol"},{"issue":"1","key":"2567_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.eururo.2012.02.020","volume":"62","author":"FE Lecouvet","year":"2012","unstructured":"Lecouvet FE, El Mouedden J, Collette L, Coche E, Danse E, Jamar F, et al. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol. 2012;62(1):68\u201375. https:\/\/doi.org\/10.1016\/j.eururo.2012.02.020.","journal-title":"Eur Urol"},{"issue":"11","key":"2567_CR21","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1097\/MNM.0000000000000566","volume":"37","author":"E Demirci","year":"2016","unstructured":"Demirci E, Sahin OE, Ocak M, Akovali B, Nematyazar J, Kabasakal L. Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET\/CT imaging. Nucl Med Commun. 2016;37(11):1169\u201379. https:\/\/doi.org\/10.1097\/MNM.0000000000000566.","journal-title":"Nucl Med Commun"},{"issue":"6","key":"2567_CR22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3322\/caac.21577","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Miller KD, Dale W, Mohile SG, Cohen HJ, Leach CR, et al. Cancer statistics for adults aged 85 years and older, 2019. CA Cancer J Clin. 2019;69(6):452\u201367. https:\/\/doi.org\/10.3322\/caac.21577.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2567_CR23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.eururo.2010.12.009","volume":"59","author":"L Dickinson","year":"2011","unstructured":"Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol. 2011;59(4):477\u201394. https:\/\/doi.org\/10.1016\/j.eururo.2010.12.009.","journal-title":"Eur Urol"},{"issue":"5","key":"2567_CR24","doi-asserted-by":"publisher","first-page":"E174","DOI":"10.5489\/cuaj.4211","volume":"11","author":"T Lee","year":"2017","unstructured":"Lee T, Hoogenes J, Wright I, Matsumoto ED, Shayegan B. Utility of preoperative 3 Tesla pelvic phased-array multiparametric magnetic resonance imaging in prediction of extracapsular extension and seminal vesicle invasion of prostate cancer and its impact on surgical margin status: experience at a Canadian academic tertiary care centre. Can Urol Assoc J. 2017;11(5):E174\u20138. https:\/\/doi.org\/10.5489\/cuaj.4211.","journal-title":"Can Urol Assoc J"},{"key":"2567_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109131","volume":"130","author":"R Wang","year":"2020","unstructured":"Wang R, Shen G, Yang R, Ma X, Tian R. 68Ga-PSMA PET\/MRI for the diagnosis of primary and biochemically recurrent prostate cancer: a meta-analysis. Eur J Radiol. 2020;130: 109131. https:\/\/doi.org\/10.1016\/j.ejrad.2020.109131.","journal-title":"Eur J Radiol"},{"issue":"Suppl 1","key":"2567_CR26","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1007\/s00259-013-2445-4","volume":"40","author":"M Souvatzoglou","year":"2013","unstructured":"Souvatzoglou M, Eiber M, Martinez-Moeller A, F\u00fcrst S, Holzapfel K, Maurer T, et al. PET\/MR in prostate cancer: technical aspects and potential diagnostic value. Eur J Nucl Med Mol Imaging. 2013;40(Suppl 1):S79-88. https:\/\/doi.org\/10.1007\/s00259-013-2445-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"2567_CR27","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.eururo.2015.12.053","volume":"70","author":"M Eiber","year":"2016","unstructured":"Eiber M, Weirich G, Holzapfel K, Souvatzoglou M, Haller B, Rauscher I, et al. Simultaneous 68Ga-PSMA HBED-CC PET\/MRI improves the localization of primary prostate cancer. Eur Urol. 2016;70(5):829\u201336. https:\/\/doi.org\/10.1016\/j.eururo.2015.12.053.","journal-title":"Eur Urol"},{"issue":"2","key":"2567_CR28","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1148\/radiol.2019190687","volume":"293","author":"UJ Muehlematter","year":"2019","unstructured":"Muehlematter UJ, Burger IA, Becker AS, Schawkat K, H\u00f6tker AM, Reiner CS, et al. Diagnostic accuracy of multiparametric MRI versus 68Ga-PSMA-11 PET\/MRI for extracapsular extension and seminal vesicle invasion in patients with prostate cancer. Radiology. 2019;293(2):350\u20138. https:\/\/doi.org\/10.1148\/radiol.2019190687.","journal-title":"Radiology"},{"issue":"6","key":"2567_CR29","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.eururo.2014.10.033","volume":"67","author":"EHJ Hamoen","year":"2015","unstructured":"Hamoen EHJ, de Rooij M, Witjes JA, Barentsz JO, Rovers MM. Use of the prostate imaging reporting and data system (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis. Eur Urol. 2015;67(6):1112\u201321. https:\/\/doi.org\/10.1016\/j.eururo.2014.10.033.","journal-title":"Eur Urol"},{"issue":"2","key":"2567_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.eururo.2015.07.029","volume":"70","author":"M de Rooij","year":"2016","unstructured":"de Rooij M, Hamoen EH, Witjes JA, Barentsz JO, Rovers MM. Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis. Eur Urol. 2016;70(2):233\u201345. https:\/\/doi.org\/10.1016\/j.eururo.2015.07.029.","journal-title":"Eur Urol"},{"issue":"11","key":"2567_CR31","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.2967\/jnumed.116.172627","volume":"57","author":"WP Fendler","year":"2016","unstructured":"Fendler WP, Schmidt DF, Wenter V, Thierfelder KM, Zach C, Stief C, et al. 68Ga-PSMA PET\/CT detects the location and extent of primary prostate cancer. J Nucl Med. 2016;57(11):1720\u20135. https:\/\/doi.org\/10.2967\/jnumed.116.172627.","journal-title":"J Nucl Med"},{"key":"2567_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101166","volume":"28","author":"Z Yang","year":"2024","unstructured":"Yang Z, Ji Y, Jia Q, Feng Y, Ji R, Bai M, et al. Real-time detection and resection of sentinel lymph node metastasis in breast cancer through a rare earth nanoprobe based NIR-IIb fluorescence imaging. Mater Today Bio. 2024;28: 101166. https:\/\/doi.org\/10.1016\/j.mtbio.2024.101166.","journal-title":"Mater Today Bio"},{"issue":"1","key":"2567_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s40001-024-01999-x","volume":"29","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Feng P, Tian F, Fong H, Yang H, Zhu H. A CT-based radiomics model for predicting lymph node metastasis in hepatic alveolar echinococcosis patients to support lymph node dissection. Eur J Med Res. 2024;29(1):409. https:\/\/doi.org\/10.1186\/s40001-024-01999-x.","journal-title":"Eur J Med Res"},{"key":"2567_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109893","volume":"143","author":"F Moradi","year":"2021","unstructured":"Moradi F, Farolfi A, Fanti S, Iagaru A. Prostate cancer: molecular imaging and MRI. Eur J Radiol. 2021;143: 109893. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109893.","journal-title":"Eur J Radiol"},{"issue":"5","key":"2567_CR35","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.eururo.2020.11.040","volume":"79","author":"JFP Lestingi","year":"2021","unstructured":"Lestingi JFP, Guglielmetti GB, Trinh QD, Coelho RF, Pontes J Jr, Bastos DA, et al. Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate-and high-risk prostate cancer: early oncological outcomes from a randomized phase 3 trial. Eur Urol. 2021;79(5):595\u2013604. https:\/\/doi.org\/10.1016\/j.eururo.2020.11.040.","journal-title":"Eur Urol"},{"issue":"5","key":"2567_CR36","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2967\/jnumed.120.257238","volume":"62","author":"A Farolfi","year":"2021","unstructured":"Farolfi A, Calderoni L, Mattana F, Mei R, Telo S, Fanti S, et al. Current and emerging clinical applications of PSMA PET diagnostic imaging for prostate cancer. J Nucl Med. 2021;62(5):596\u2013604. https:\/\/doi.org\/10.2967\/jnumed.120.257238.","journal-title":"J Nucl Med"},{"issue":"7","key":"2567_CR37","doi-asserted-by":"publisher","first-page":"12247","DOI":"10.18632\/oncotarget.14691","volume":"8","author":"S Zang","year":"2017","unstructured":"Zang S, Shao G, Cui C, Li TN, Huang Y, Yao X, et al. 68Ga-PSMA-11 PET\/CT for prostate cancer staging and risk stratification in Chinese patients. Oncotarget. 2017;8(7):12247\u201358. https:\/\/doi.org\/10.18632\/oncotarget.14691.","journal-title":"Oncotarget"},{"issue":"24","key":"2567_CR38","doi-asserted-by":"publisher","first-page":"6300","DOI":"10.1158\/1078-0432.CCR-18-0768","volume":"24","author":"B Grubm\u00fcller","year":"2018","unstructured":"Grubm\u00fcller B, Baltzer P, Hartenbach S, D\u2019Andrea D, Helbich TH, Haug AR, et al. PSMA ligand PET\/MRI for primary prostate cancer: staging performance and clinical impact. Clin Cancer Res. 2018;24(24):6300\u20137. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0768.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2567_CR39","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","volume":"21","author":"EM Schaeffer","year":"2023","unstructured":"Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, et al. Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21(10):1067\u201396. https:\/\/doi.org\/10.6004\/jnccn.2023.0050.","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"2567_CR40","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.juro.2007.10.059","volume":"179","author":"TK Choueiri","year":"2008","unstructured":"Choueiri TK, Dreicer R, Paciorek A, Carroll PR, Konety B. A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy. J Urol. 2008;179(3):906\u201310. https:\/\/doi.org\/10.1016\/j.juro.2007.10.059.","journal-title":"J Urol"},{"issue":"2","key":"2567_CR41","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00259-020-04981-x","volume":"48","author":"A Santos","year":"2021","unstructured":"Santos A, Mattiolli A, Carvalheira JB, Ferreira U, Camacho M, Silva C, et al. PSMA whole-body tumor burden in primary staging and biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging. 2021;48(2):493\u2013500. https:\/\/doi.org\/10.1007\/s00259-020-04981-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"2567_CR42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332. https:\/\/doi.org\/10.3322\/caac.21338.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"2567_CR43","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1097\/PAS.0b013e3181fc679e","volume":"34","author":"Y Tokuda","year":"2010","unstructured":"Tokuda Y, Carlino LJ, Gopalan A, Tickoo SK, Kaag MG, Guillonneau B, et al. Prostate cancer topography and patterns of lymph node metastasis. Am J Surg Pathol. 2010;34(12):1862\u20137. https:\/\/doi.org\/10.1097\/PAS.0b013e3181fc679e.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2567_CR44","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00259-017-3631-6","volume":"44","author":"C Uprimny","year":"2017","unstructured":"Uprimny C, Kroiss AS, Decristoforo C, Fritz J, von Guggenberg E, Kendler D, et al. 68Ga-PSMA-11 PET\/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour. Eur J Nucl Med Mol Imaging. 2017;44(6):941\u20139. https:\/\/doi.org\/10.1007\/s00259-017-3631-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"2567_CR45","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/MNM.0000000000001370","volume":"42","author":"A Aksu","year":"2021","unstructured":"Aksu A, Karahan \u015een NP, Tuna EB, Aslan G, \u00c7apa KG. Evaluation of 68Ga-PSMA PET\/CT with volumetric parameters for staging of prostate cancer patients. Nucl Med Commun. 2021;42(5):503\u20139. https:\/\/doi.org\/10.1097\/MNM.0000000000001370.","journal-title":"Nucl Med Commun"},{"issue":"10","key":"2567_CR46","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/pros.24350","volume":"82","author":"RS Flammia","year":"2022","unstructured":"Flammia RS, Hoeh B, Sorce G, Chierigo F, Hohenhorst L, Tian Z, et al. Contemporary seminal vesicle invasion rates in NCCN high-risk prostate cancer patients. Prostate. 2022;82(10):1051\u20139. https:\/\/doi.org\/10.1002\/pros.24350.","journal-title":"Prostate"},{"issue":"5","key":"2567_CR47","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/21681805.2019","volume":"53","author":"S Wu","year":"2019","unstructured":"Wu S, Lin X, Lin SX, Lu M, Deng T, Wang Z, et al. Impact of biopsy perineural invasion on the outcomes of patients who underwent radical prostatectomy: a systematic review and meta-analysis. Scand J Urol. 2019;53(5):287\u201394. https:\/\/doi.org\/10.1080\/21681805.2019.","journal-title":"Scand J Urol"},{"key":"2567_CR48","doi-asserted-by":"publisher","unstructured":"Preisser F, Heinze A, S Abrams-Pompe R, Bud\u00e4us L, Chun FK, Graefen M, et al. Impact of positive surgical margin length and Gleason grade at the margin on oncologic outcomes in patients with nonorgan-confined prostate cancer. Prostate. 2022;82(9):949\u201356. https:\/\/doi.org\/10.1002\/pros.24341.","DOI":"10.1002\/pros.24341"},{"issue":"2","key":"2567_CR49","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s00259-017-3852-8","volume":"45","author":"M Sathekge","year":"2018","unstructured":"Sathekge M, Lengana T, Maes A, Vorster M, Zeevaart J, Lawal I, et al. 68Ga-PSMA-11 PET\/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans. Eur J Nucl Med Mol Imaging. 2018;45(2):226\u201334. https:\/\/doi.org\/10.1007\/s00259-017-3852-8.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02567-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02567-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02567-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T03:14:09Z","timestamp":1745205249000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02567-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2567"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02567-7","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the First Affiliated Hospital of Anhui Medical University (Ethical Code: PJ2022-05-21).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"311"}}